-+ 0.00%
-+ 0.00%
-+ 0.00%

REZERA: RESOLVE-2 PHASE 2 TRIAL SHOWS RUVONOFLAST PLUS SEMAGLUTIDE ACHIEVED GREATER HSCRP REDUCTIONS VS SEMAGLUTIDE ALONE

Reuters·10/07/2026 12:00:20

Please log in to view news